About
Al Parker
Founder & CEO
Business and Legal Executive with 30+ Years of Global Experience in Life Sciences and Healthcare
With over three decades of leadership in the life sciences and healthcare sectors, Al is a strategic business builder who has played pivotal roles in driving corporate growth, executing high-value transactions, and navigating challenging business environments and complex legal and regulatory landscapes. As a business owner and former executive for publicly traded companies ranging in size from the Fortune 125 to small cap, Al has worked extensively with boards and management teams to increase shareholder value by successfully traversing complex matters including large scale M&A transactions, equity capital raises and debt financings, shareholder activism challenges, new product launches, high-stakes litigation, cybersecurity breaches, and enterprise risk management on a global scale.
After more than two decades in senior positions at major corporations and law firms, Al founded and has led GC Legal Advisors, an innovative consultancy focused on advising and supporting the boards and executive teams of life sciences companies, since 2010. While leading the firm, he has periodically stepped away from day-to-day management to assume key C-suite roles with certain companies at critical times of their growth and evolution, driving a series of successful exits. These roles have included COO at a Nasdaq-listed molecular diagnostic company and CEO of a subsidiary business, CLO and Corporate Secretary of a therapeutics firm where he led its acquisition by a larger publicly traded company, and CLO and Corporate Secretary of the global pharmaceutical subsidiary of a publicly traded Japanese conglomerate.
A Strategic Client Advisor
Al’s career path includes partnership at an AmLaw 200 firm and senior in-house counsel roles at Fortune 125 and multinational companies. He has served as a trusted advisor to numerous CEOs and boards and has led and developed high-performing legal, compliance, and government affairs teams on a global scale to facilitate sustained growth in domestic and international markets. His oversight has extended across commercial operations, R&D, corporate governance, IT and cybersecurity, enterprise risk management, and Al has been the strategic architect of multiple acquisitions across various company sizes.
Boardroom Experience
As a member of the C-suite in various capacities, Al has gained deep public company boardroom experience, offering both business and legal counsel on a wide range of matters, from corporate governance and enterprise risk management to operational strategy. In addition, Al has served on several private company and nonprofit boards, including Frontline Pharmaceuticals, the Thomas Jefferson University Hospitals, Inc., the American Arbitration Association, and Philadelphia Youth Basketball, among others, with roles including Nominating and Governance Chair, Development Chair, and Executive, Audit & Finance, and Real Estate committee member. Al's commitment to governance excellence is underscored by his Directorship Certification from the National Association of Corporate Directors.
Education
University of Pennsylvania Law School, JD
Editor, University of Pennsylvania Law Review
Penn State University, Economics/Finance, BA
Certifications & Bar Admissions
NACD Directorship Certification, NACD Governance Fellow
Pennsylvania, Maryland, District of Columbia, and various federal courts